Challenges and opportunities for pharmacoepidemiology in drug‐therapy decision making

M Etminan, S Gill, M FitzGerald… - The Journal of Clinical …, 2006 - Wiley Online Library
Pharmacoepidemiology is a relatively new and evolving science that attempts to quantify
mainly adverse drug events and patterns of drug use in a large population. The strength of …

Challenges and opportunities for pharmacoepidemiology in drug-therapy decision making.

M Etminan, S Gill, M FitzGerald, A Samii - 2006 - cabidigitallibrary.org
Pharmacoepidemiology is a relatively new and evolving science that attempts to quantify
mainly adverse drug events and patterns of drug use in a large population. The strength of …

Challenges and opportunities for pharmacoepidemiology in drug-therapy decision making

M Etminan, S Gill, M Fitzgerald… - Journal of clinical …, 2006 - pubmed.ncbi.nlm.nih.gov
Pharmacoepidemiology is a relatively new and evolving science that attempts to quantify
mainly adverse drug events and patterns of drug use in a large population. The strength of …

Challenges and opportunities for pharmacoepidemiology in drug-therapy decision making.

M Etminan, S Gill, M Fitzgerald… - Journal of Clinical …, 2006 - europepmc.org
Pharmacoepidemiology is a relatively new and evolving science that attempts to quantify
mainly adverse drug events and patterns of drug use in a large population. The strength of …

Challenges and opportunities for pharmacoepidemiology in drug-therapy decision making.

M Etminan, S Gill, M FitzGerald, A Samii - Journal of Clinical …, 2006 - go.gale.com
Pharmacoepidemiology is a relatively new and evolving science that attempts to quantify
mainly adverse drug events and patterns of drug use in a large population. The strength of …

[引用][C] Challenges and opportunities for pharmacoepidemiology in drug-therapy decision making

M ETMINAN, S GILL, M FITZGERALD… - Journal of clinical …, 2006 - Sage Publications